RCM
GILD icon

Richardson Capital Management’s Gilead Sciences GILD Stock Holding History

Richardson Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$152K Hold
1,200
– – 0.06% 63
2026
Q1 		$167K Hold
1,200
– – 0.08% 53
2025
Q4 		$147K Hold
1,200
– – 0.07% 49
2025
Q3 		$133K Hold
1,200
– – 0.06% 51
2025
Q2 		$133K Hold
1,200
– – 0.07% 50
2025
Q1 		$134K Buy
+1,200
New +$124K 0.08% 48

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Richardson Capital Management's GILD Position: Q2 2026 in Review

Richardson Capital Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,200 shares worth $152K. The position accounts for 0.06% of the portfolio, ranked #63.

Richardson Capital Management first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $167K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Richardson Capital Management held 1,200 shares of Gilead Sciences worth $152K as of Q2 2026.
  • Richardson Capital Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.06% of Richardson Capital Management's portfolio in Q2 2026, its #63 holding.
  • Richardson Capital Management first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Richardson Capital Management's Gilead Sciences position peaked at $167K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Richardson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.